362 related articles for article (PubMed ID: 10840940)
21. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
22. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
Zhang S; Yuan S
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
[TBL] [Abstract][Full Text] [Related]
23. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
24. Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase.
Li Z; Shanmugam N; Katayose D; Huber B; Srivastava S; Cowan K; Seth P
Cancer Gene Ther; 1997; 4(2):113-7. PubMed ID: 9080120
[TBL] [Abstract][Full Text] [Related]
25. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
[TBL] [Abstract][Full Text] [Related]
26. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
[TBL] [Abstract][Full Text] [Related]
27. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma.
Lan KH; Kanai F; Shiratori Y; Ohashi M; Tanaka T; Okudaira T; Yoshida Y; Hamada H; Omata M
Cancer Res; 1997 Oct; 57(19):4279-84. PubMed ID: 9331089
[TBL] [Abstract][Full Text] [Related]
28. Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.
McCart JA; Puhlmann M; Lee J; Hu Y; Libutti SK; Alexander HR; Bartlett DL
Gene Ther; 2000 Jul; 7(14):1217-23. PubMed ID: 10918490
[TBL] [Abstract][Full Text] [Related]
29. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter.
Cao G; Kuriyama S; Gao J; Kikukawa M; Cui L; Nakatani T; Zhang X; Tsujinoue H; Pan X; Fukui H; Qi Z
Gene Ther; 1999 Jan; 6(1):83-90. PubMed ID: 10341879
[TBL] [Abstract][Full Text] [Related]
30. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity.
Lee YJ; Lee H; Borrelli MJ
Cancer Gene Ther; 2002 Mar; 9(3):267-74. PubMed ID: 11896443
[TBL] [Abstract][Full Text] [Related]
31. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
[TBL] [Abstract][Full Text] [Related]
32. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
[TBL] [Abstract][Full Text] [Related]
33. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy of metastatic colon carcinoma: regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase.
Block A; Freund CT; Chen SH; Nguyen KP; Finegold M; Windler E; Woo SL
Cancer Gene Ther; 2000 Mar; 7(3):438-45. PubMed ID: 10766350
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine.
Lü HZ; Wu DZ; Wan YL; Gu B; Gao HZ; Liang YQ; Wang JX
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):440-4. PubMed ID: 10678093
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma.
Ju DW; Tao Q; Cheng DS; Zhang W; Zhang M; Hamada H; Cao X
Gene Ther; 2000 Feb; 7(4):329-38. PubMed ID: 10694814
[TBL] [Abstract][Full Text] [Related]
37. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.
Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM
Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
Khil MS; Kim JH; Mullen CA; Kim SH; Freytag SO
Clin Cancer Res; 1996 Jan; 2(1):53-7. PubMed ID: 9816090
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy for cancer using tumour-specific prodrug activation.
Harris JD; Gutierrez AA; Hurst HC; Sikora K; Lemoine NR
Gene Ther; 1994 May; 1(3):170-5. PubMed ID: 7584078
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism].
Ju D; Cao X; Wang B
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):108-11. PubMed ID: 10920957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
